No Data
US Stock MarketDetailed Quotes
MTNB Matinas BioPharma
Watchlist
0.2049
-0.0051-2.43% Close 11/27 16:00 ET
0.2136+0.0087+4.25%
Pre 04:31 ET
0.2211High0.2049Low2.16MVolume
0.2147Open0.2100Pre Close457.11KTurnover1.03%Turnover RatioLossP/E (TTM)44.52MMarket Cap0.890052wk HighLossP/E (Static)217.26MShares0.110352wk Low1.91P/B43.13MFloat Cap3.9500Historical High--Dividend TTM210.48MShs Float0.1103Historical Low--Div YieldTTM7.71%Amplitude0.2110Avg Price1Lot Size
Pre-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About Matinas BioPharma Company
Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanocrystal platform delivery technology to maximize global clinical impact and patient access. The company was founded by Herbert J. Conrad and Jerome D. Jabbour in May 2013 and is headquartered in Bedminster, NJ.
Revenue Breakdown
Business
Unit:USD
2022/12/31
Stock NameRevenueRatio
Single Segment3.19M100.00%
News
Comments
$Matinas BioPharma(MTNB.US$ bought some lets move on
Nov 17 low priced watchlists
$Sidus Space(SIDU.US$$Inpixon(INPX.US$ $CN Energy(CNEY.US$$AERWINS Technologies(AWIN.US$$NFT Ltd(MI.US$$The Beachbody(BODY.US$$AEye(LIDR.US$$SenesTech(SNES.US$$Atreca(BCEL.US$$Comera Life Sciences(CMRA.US$ $Matinas BioPharma(MTNB.US$$NOCO-NOCO(NCNC.US$$Aterian(ATER.US$$Precision BioSciences(DTIL.US$$Singular Genomics(OMIC.US$$Remark Holdings(MARK.US$$GoldMining(GLDG.US$$Heron Therapeutics(HRTX.US$ $WISeKey(WKEY.US$$Aileron Therapeutics(ALRN.US$$Collective Audience(CAUD.US$$Plus Therapeutics(PSTV.US$$Metalla Royalty & Streaming(MTA.US$$Turnstone Biologics(TSBX.US$$SYLA Technologies(SYT.US$$Itau Unibanco(ITUB.US$
2
Read more
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--